Clin2
NCT07592572Likely a fitCompleted

How Itraconazole Affects a New Study Drug in Healthy Adults

Healthy

Treatments studied

This study tests how a common antifungal medication (itraconazole) changes how the body processes an experimental drug (LY4395089). Researchers enroll healthy volunteers to understand if these two drugs interact safely together.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
14 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You must be in overall good health with no serious heart, lung, liver, kidney, stomach, or nerve conditions
  • Your liver function tests must be normal or only slightly elevated (not more than 1.25 times the upper limit of normal)
  • You cannot have HIV, hepatitis B, or hepatitis C
  • Your body mass index (BMI) must be between 18 and 32 (a measure of height-to-weight ratio)
  • You cannot have smoked or used nicotine products in the past 3 months
  • You must be able to stay at a research clinic for the study duration and follow all study procedures

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07685600Recruiting· Phase 1
Drug interaction study of AZD4144 and itraconazole

This trial checks if a new drug (AZD4144) works differently when taken with an antifungal medicine (itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for people who need both medicines.

Harrow
NCT07339722Recruiting· Phase 1
Study of LY4515100 in healthy volunteers

This trial tests a new oral medication in healthy volunteers to see how it moves through the body and how safe it is. Taking part helps researchers understand how the drug works before it's studied in people with a certain condition.

Dallas, Texas
NCT06662773Not yet recruiting· Phase 1
Study of TQB3616 drug interactions in healthy volunteers

This study tests how a new drug called TQB3616 interacts with other medicines. It is for healthy volunteers aged 18 to 45 to help understand how the drug is processed in the body.

Beijing, Beijing Municipality
NCT07774325Not yet recruiting· Phase 1
Study of BI 3002022 in healthy men

This study tests how a drug called BI 3002022 interacts with certain transport proteins in healthy men. It may help researchers understand how the drug is absorbed and eliminated by the body.

Biberach
NCT07661108Recruiting· Phase 1
Healthy volunteer study of an experimental drug

This study tests an experimental drug called MK-8527 in healthy people. It helps researchers understand how the drug works in the body before it is studied in patients with a medical condition.

Daytona Beach, Florida
NCT07535970Not yet recruiting· Phase 1
How itraconazole affects a new drug in healthy adults

This early-stage study tests how a common antifungal medication (itraconazole) changes how your body processes a new experimental drug called HS-10506. Researchers enroll healthy volunteers to understand safe dosing before testing in patients with real medical conditions.

Jinan, Shandong

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.